Raymond James Updates Healthcare Top Picks for October
Raymond James updated its Healthcare Top Picks for October, adding Xencor (XNCR), Calyxt (CLYM), and UnitedHealth Group (UNH), while removing Relay Therapeutics, Tyra Biosciences, and Oscar Health. The firm cited near-term catalysts for Xencor and Calyxt, and expects strong earnings from UnitedHealth.
How this was made
The 30-second read
Why it matters
The changes reflect analyst confidence in near‑term catalysts for XNCR, CLYM, and UNH.
Market read
Analyst list updates can drive short‑term buying interest in the highlighted stocks.
What to watch
Potential regulatory or trial setbacks could reverse the upside.
Background
Raymond James refreshed its monthly healthcare watchlist, swapping three stocks for three new ones.
Ticker impact
Raymond James added Xencor to its Healthcare Top Picks, citing a near‑term catalyst from the XmAb819 trial readout.
likely upside as traders price in the upcoming trial data.
The addition signals confidence in near‑term data, prompting buying interest.
Calyxt was added to the list, highlighted for derisked assets and upcoming Phase‑2 data on CLYM116.
potential upward pressure ahead of Phase‑2 readout.
Analyst expects data to de‑risk the stock, encouraging accumulation.
UnitedHealth Group was added ahead of its Q3 earnings, viewed as a strong quarter despite market pullback.
likely buying pressure before earnings release.
Placement signals confidence in earnings beat, prompting pre‑earnings positioning.
Market effects
The upgrades may lift sentiment across the healthcare sector.
U.S. markets may see modest gains in biotech and health‑care stocks.
Limited to U.S. listed healthcare names; no broader macro effect.
Counterpoint
Some investors may view the picks as premature without concrete data releases.
Key entities
- analyst_firmRaymond James
Provider of the healthcare top‑picks list.
